Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLITZ: Itraconazole vs Prednisolone + Itraconazole in ABPA-CPA Overlap Syndrome
NCT05444946Recruiting
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Jun 2022
- Primary completion
- Jan 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of prednisolone in chronic pulmonary aspergillosis (CPA) and allergic bronchopulmonary aspergillosis (ABPA) (2 arms), sponsored by Post Graduate Institute of Medical Education and Research. Primary endpoint: Favourable response at six months at 6 months. Started Jun 2022; status: recruiting.
02
Drugs
prednisolone
03
Conditions
chronic pulmonary aspergillosis (CPA)allergic bronchopulmonary aspergillosis (ABPA)
Beyond the preview
Go deeper on NCT05444946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05444946.